Company intelligence / Profile preview

CapitalX

San Francisco, California, United Statescapitalx.company ↗

Ownership: Private
Development stage: Other

Overview

Not applicable; CapitalX does not develop drugs or therapies. It is an early-stage venture capital fund led by Cindy Bi, focused on investing in startups across various sectors, including but not limited to technology and potentially healthcare[1]. No evidence suggests it directly develops therapeutics or diagnostics.

Industry: Investors

Partnerships

Not specified; as a VC fund, may have portfolio companies but no direct pharma/biotech partnerships listed

Beyond the preview

Go deeper on CapitalX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CapitalX.

Explore the full profile